v3.25.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Current Assets:    
Cash and cash equivalents $ 547,890 $ 884,377
Investments held in marketable securities 10,184,701 10,181,618
Accounts receivable 188,400 19,300
Prepaid expenses and other current assets 223,230 305,231
Total Current Assets 11,144,221 11,390,526
Deferred offering costs 148,697
Property and equipment, net 362,936 356,055
Right-of-use assets 151,447
Intangible assets, net 623,945 713,692
Total Assets 12,279,799 12,611,720
Current Liabilities:    
Accounts payable 483,070 189,389
Accrued expenses and other current liabilities 744,485 711,686
Lease liability 162,317
Warrant liabilities 2,520,851 1,543,953
Total Current Liabilities 3,748,406 2,607,345
Total Liabilities 3,748,406 2,607,345
Commitments and contingencies
Stockholders’ Equity:    
Common stock, $0.0001 par value; 75,000,000 shares authorized; 6,919,919 and 4,706,917 shares issued and outstanding at December 31, 2024 and 2023, respectively 692 471
Additional paid-in capital 164,195,434 156,689,256
Accumulated deficit (155,678,715) (146,699,334)
Total Stockholders’ Equity 8,531,393 10,004,375
Total Liabilities and Stockholders’ Equity 12,279,799 12,611,720
Series B Convertible Preferred Stock [Member]    
Stockholders’ Equity:    
Preferred stock, value $ 13,982 $ 13,982

Source

10-K XBRL Zip